Industry Report

Pharmaceutical and healthcare market in Poland

Market analysis and development forecasts for 2018-2023

This product is also available in Polish

Pharmaceutical and healthcare market in Poland

Market analysis and development forecasts for 2018-2023

Infographic Brochure Index and sample pages
Other versions: Polish
Sector: Pharmaceuticals & Parapharmaceuticals
Country: Poland

This report presents complete information and in-depth analysis of the Polish pharmaceutical market, broken down into the pharmacy and hospital segments and organised by category of ATC medicine. It contains information on all major manufacturers and best-selling products among Poland’s consumers. 

The document includes analysis of the Polish healthcare segment, according to key aspects such as: total numbers of public and private hospitals, number of beds at each facility, the number of doctors by specialisation and the total value of health care spending in Poland. 

Additional key elements of this report include pharmaceutical market value and development forecasts for the period 2018 to 2023 as well as information illustrating consumer preferences when purchasing medicines and choosing specific health care services.


What is the content of the report?

  • Value of the entire pharmaceutical market and of each category of ATC pharmaceuticals
  • Market development forecasts for the period 2018 to 2023 – for the overall market and for several ATC categories 
  • Major pharmaceutical manufacturers operating in Poland
  • Best-selling drugs and dietary supplements in Poland
  • The current sales totals for the most widely-used categories of ATC drugs, as well as sales forecasts for the coming years
  • Barriers and supporting factors that influence the development of the entire market and each individual category of medicines and health services
  • Detailed analysis of the current legal status, as well as possible future legal changes
  • Comprehensive data on the reimbursement process in Poland, including the application, refund rules, major practical problems, expenses for the refund, products of the highest refund to open reimbursement (pharmacy market), chemotherapy and drug programs
  • Analysis of generic substitution
  • List of drug programs existing in Poland, along with active substances
  • Poland’s national reimbursement policy, with presentation and impact analysis of the most recent changes to reimbursement lists and possible modifications in the future
  • Total spending of NFZ on medication refunds, including ATC classification category, the voivodship and the level of payment required from the patient
  • Epidemiological trends in Poland, including data describing the most common diseases and the most common cause of death in Poland
  • Consumer behaviour related to the purchase of drugs and use of specific healthcare services.

Why to buy the report?

  • Monitoring the development and changes taking place in Poland’s pharmaceutical and healthcare market
  • Planning a new pharmaceutical or medical investment
  • Making decisions regarding financial support for entities operating in this market
  • Development of a product portfolio using ATC identification to determine categories that offer the highest growth potential
  • Analysis of potential investment and credit risks in this market
  • Performing merger or acquisition transactions 
  • Analysis of current business operations, performance and growth plans of the competition
  • Preparation of corporate development strategies and budgets based on reliable forecasts for market development over the next five years
  • Estimating demand for various categories of medicines and types of healthcare services
  • Preparing to enter the pharmaceutical and medical market in Poland
  • Beginning business operations in new segments of this market.

Who benefits from the analysis?

  • Financial institutions interested in the pharmaceutical and healthcare market in Poland, including banks, brokerage houses and investment funds
  • Consulting companies, research agencies, governments and research bodies that monitor the Polish pharmaceutical and medical industry
  • Marketing agencies serving pharmaceutical and medical companies
  • Drug manufacturers and producers operating in the market
  • Pharmaceutical distributors 
  • Hospitals, both public and non-public
  • Non-hospital providers of healthcare services.
Table of Contents
  • Methodology
  • Executive summary

More info

For details on price and content please call:
+48 782 011 000
or email

Other versions: Polish
Sector: Pharmaceuticals & Parapharmaceuticals
Country: Poland

Find out more!

Get index, sample pages and additional data:

Index and sample pages

Unlimited sharing and use of the Product inside one Organisation.

For more information please visit:

This content is available for current PMR clients. If you are a client please log-in or contact us for more information at: +48 782 011 000.

Jest to zawartość dostępna dla obecnych klientów PMR. Jeśli jesteś klientem, zaloguj się lub skontaktuj się z nami, aby uzyskać więcej informacji: +48 782 011 000.